NCT06810622 NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
| NCT ID | NCT06810622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Kidney Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 448 participants |
| Start Date | 2026-03-18 |
| Primary Completion | 2029-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 448 participants in total. It began in 2026-03-18 with a primary completion date of 2029-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching goal of this project is to refine and adapt previous work on the NAVIGATE-Kidney project for individuals with CKD. The investigators hypothesize that the multilevel NAVIGATE-Kidney program intervention will reduce the rate of central venous catheter use at KRT start (primary outcome), increase the rate of optimal KRT starts (secondary outcome), increase patient activation, and reduce decisional conflict (patient-centered outcomes) for individuals with advanced CKD. The project will have four (4) aims.
Eligibility Criteria
Inclusion Criteria: * Adults ≥ 18 years of age, * Adults who are not pregnant, * Adults who are not incarcerated, * Adults who have advanced kidney disease with an eGFR of 15-29 mL/min/1.73m2). No other measures are used to identify eligible patients. Exclusion Criteria: * Previous kidney transplant * Previous surgery for dialysis such as an arteriovenous fistula, arteriovenous graft, or peritoneal dialysis catheter placement * On chronic dialysis * Conservative management or primary goal is palliation * Incarcerated * Pregnant\* * Under 18 years of age * Moderate to severe dementia * Deaf persons * Lacking health insurance\*\* * Investigator Discretion: Individuals who, in the judgment of the Site PI (or designee), are deemed unsuitable for participation due to behavioral or logistical circumstances that could compromise study integrity or the safety of the participant or staff.
Contact & Investigator
Lilia Cervantes, MD
PRINCIPAL INVESTIGATOR
University of Colorado-Anschutz SOM-Hospital Medicine
Frequently Asked Questions
Who can join the NCT06810622 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06810622 currently recruiting?
Yes, NCT06810622 is actively recruiting participants. Contact the research team at lilia.cervantes@cuanschutz.edu for enrollment information.
Where is the NCT06810622 trial being conducted?
This trial is being conducted at Denver, United States, Albuquerque, United States.
Who is sponsoring the NCT06810622 clinical trial?
NCT06810622 is sponsored by University of Colorado, Denver. The principal investigator is Lilia Cervantes, MD at University of Colorado-Anschutz SOM-Hospital Medicine. The trial plans to enroll 448 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.